Skip to main content

Research News

Join WhatsApp Channel 

Regulatory Affairs Courses
  • KemPharm, Inc. announced that the New Drug Application (NDA) for KP201/APAP, its investigational drug candidate for the short-term management of acute pain, has been accepted and granted priority review by the U.S. Food and Drug Administration (FDA).  In addition, the FDA has set a target action date under the Prescription Drug User Fee Act (PDUFA) of June 9, 2016.

  • After the age of nine months, the development of the infant gut microbiota is driven by diet, not maternal obesity, a new study says.The gut microbiota is a complex community of microorganisms that live in the digestive tract.

    [adsense:336x280:8701650588]

  • Feeding fish oil-based diet for three weeks has been found to slow progression of Alzheimer's like symptoms in mouse models of the disease, reports a new study, supporting viability of a dietary approach to combat the brain disorder in humans.

  • Researchers have found that a US Food and Drug Administration (FDA)-approved drug currently used for obese patients and Type-2 diabetics has the potential to be used in the treatment of cocaine dependence.

  • British researchers have identified a key protein that can control how breast cancer cells spread in the body.The study sheds light on how cancer cells leave the blood vessels to travel to a new part of the body, said the researchers from University of Manchester in Britain.

Subscribe to Research News